Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells

被引:0
作者
Q Yang
J Huang
Q Wu
Y Cai
L Zhu
X Lu
S Chen
C Chen
Z Wang
机构
[1] Bengbu Medical College,Department of Biochemistry and Molecular Biology
[2] Clinical Testing and Diagnose Experimental Center of Bengbu Medical College,Department of Medical Oncology
[3] First Affiliated Hospital of Bengbu Medical College,undefined
[4] Cyrus Tang Hematology Center,undefined
[5] Jiangsu Institute of Hematology,undefined
[6] First Affiliated Hospital of Soochow University,undefined
来源
British Journal of Cancer | 2014年 / 110卷
关键词
breast cancer; chemoresistance; paclitaxel; Skp2; EMT;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1958 / 1967
页数:9
相关论文
共 291 条
[1]  
Ali S(2002)Endocrine-responsive breast cancer and strategies for combating resistance Nat Rev Cancer 2 101-112
[2]  
Coombes RC(2010)Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis Nat Cell Biol 12 457-467
[3]  
Chan CH(2012)The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis Cell 149 1098-1111
[4]  
Lee SW(2013)Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression Cell 154 556-568
[5]  
Li CF(2013)Breast cancer in 2012: new drugs, new knowledge, new targets Nat Rev Clin Oncol 10 75-76
[6]  
Wang J(2008)Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy Blood 111 4690-4699
[7]  
Yang WL(2013)Establishment of Paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms Asian Pac J Cancer Prev 14 6135-6140
[8]  
Wu CY(2008) and Breast Cancer Res 10 R63-110
[9]  
Wu J(2013)Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer Nat Rev Cancer 13 97-1118
[10]  
Nakayama KI(2013)Regulatory networks defining EMT during cancer initiation and progression Oncol Rep 30 1113-381